Patient Guide: Datopotamab Deruxtecan (Dato-DXd) in Combination With Pembrolizumab With or Without Platinum Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-Lung02)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 24 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04526691
Status: ACTIVE_NOT_RECRUITING
Condition: Advanced or Metastatic NSCLC
Phase: PHASE1

Where You Can Participate

This study is available at 24 locations across the country.

Top locations include:
  • • Scottsdale, Arizona
  • • Duarte, California
  • • Washington, District of Columbia
  • • And 21 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Datopotamab Deruxtecan (Dato-DXd) in Combination With Pembrolizumab With or Without Platinum Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-Lung02) - Join Clinical Trial NCTNCT04526691

How to Join This Clinical Trial - NCTNCT04526691

Learn how to participate in this PHASE1 trial studying an investigational therapy for Advanced or Metastatic NSCLC. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Advanced or Metastatic NSCLC. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Advanced or Metastatic NSCLC
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04526691 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 24 locations. Find a study site near you:

Clinical Research Site

Scottsdale, Arizona 85259 - United States

Status: Contact for availability

Clinical Research Site

Duarte, California 91010 - United States

Status: Contact for availability

Clinical Research Site

Washington, District of Columbia 20016 - United States

Status: Contact for availability

Clinical Research Site

Jacksonville, Florida 32224 - United States

Status: Contact for availability

Clinical Research Site

Baltimore, Maryland 21224 - United States

Status: Contact for availability

Clinical Research Site

Baltimore, Maryland 21287 - United States

Status: Contact for availability

Clinical Research Site

Rochester, Minnesota 55905 - United States

Status: Contact for availability

Clinical Research Site

Santa Fe, New Mexico 87505 - United States

Status: Contact for availability

Clinical Research Site

San Antonio, Texas 78229 - United States

Status: Contact for availability

Clinical Research Site

Milan, 20141 - Italy

Status: Contact for availability

And 14 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Advanced or Metastatic NSCLC:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships